Stay updated on Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing Revision: v3.4.2. This appears to be a minor UI/versioning update and does not affect the study information.
    Difference
    0.0%
    Check dated 2026-03-10T00:01:15.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied, replacing the previous v3.4.1. This update seems to be a metadata/version change with no visible impact on study details or page content.
    Difference
    0.0%
    Check dated 2026-02-16T15:20:28.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed, indicating a minor internal software update with no changes to page content or trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-09T12:15:27.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Adds a glossary toggle and new update timestamp labels (Last Update Submitted that Met QC Criteria and Last Update Posted) to the study details page, while removing the older QC label, the 'Last Update Posted (Estimated)' tag, the 'No FEAR Act data' wording, and the previous revision tag (v3.3.4).
    Difference
    0.1%
    Check dated 2026-02-02T09:24:14.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page shows a minor site revision from v3.3.3 to v3.3.4 with no changes to study content or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-19T05:55:47.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Expanded the study Locations to include numerous sites across the US, Canada, Europe, and Australia, with many regional entries added and others removed.
    Difference
    4%
    Check dated 2025-12-21T21:33:23.000Z thumbnail image

Stay in the know with updates to Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.